Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.
Amgen
Venture Capital Firm, Other
Amgen is a global biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative therapies for serious illnesses. It leverages human genetics and advanced science to improve health outcomes and transform patient lives.
Overview and Management
Establishment Year
1980
Mission
To serve patients by transforming the potential of science and biotechnology into therapies that restore health or save lives.
Values
Integrity, Innovation, Collaboration, Accountability, Respect, Excellence, Trust, Quality, and Teamwork.
Investment Roles
Capital Allocator, Direct Investor
Participant Demographics
Patients suffering from serious illnesses globally, including underserved and diverse populations.
Generational Wealth Planning
Risk Tolerance
References or Case Studies
Team Experience
Notable Achievements
Numerous accolades, including being named one of the "World's Most Innovative Companies" (2023) and recognition for disability inclusion and sustainability.
Project Track Record
Development of transformative medicines such as EPOGEN¨, NEUPOGEN¨, Prolia¨, and more.
Exit Strategies
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance with ethical research, patient safety, and product quality standards.
Compliance History
No major violations mentioned.
Phone Number
Address
Thousand Oaks United States